IN preceding investigations (Benassi, Perissinotto and Allegri, 1963) we studied the excretion of tryptophan metabolites in 201 patients with bladder tumours, 55 subjects suffering from tumours of the urinary system, particularly of kidney (Perissinotto, Benassi and Allegri, 1964) , and 112 individuals with various nonneoplastic urological diseases. Abnormal levels of urinary kynurenine, 3-hydroxykynurenine and 3-hydroxyanthranilic acid were detectable in certain patients in all three groups with a higher frequency in those with kidney neoplasm.
cancer.
Since the presence of metabolites in biologic fluid depends upon specific enzyme activities we thought it of interest to study several of the enzymes involved in the intermediary metabolism of tryptophan.
In the present investigation tryptophan pyrrolase, kynureninase, anid kynurenine transaminase were measured in normal and neoplastic human kidneys, since it was observed (Perissinotto et al., 1964 ) that a higher and more frequent excretion of the so-called oncogenic metabolites occurred in patients with renal neoplasm.
Tryptophan pyrrolase firstly attacks tryptophan causing oxidative breakdown of the indole ring yielding NI-formylkynurenine. It is present in mammalian, amphibian and avian liver and also in insects, some bacteria and fungi. Animal kidney seems to lack such an enzyme.
It has been isolated as ferriheme inactive protein and its levels in liver are under adaptive control: enzyme activity arises with increasing substrate concentration (induction by substrate) and furthermore by hormonal action (hormonal induction), and it is, in general terms, concerned with protein synthesis.
Kynureninase causes cleavage of the alanine chain of kynurenine and 3-hydroxykynurenine forming anthranilic and 3-hydroxyanthranilic acids respectively. It requires pyridoxal-5-phosphate as a coenzyme.
Kynurenine transaminase is also a pyridoxal-phosphate-dependent enzyme and catalyses the transformation of kynurenine to kynurenic acid and 3-hydroxykynurenine to xanthurenic acid.
Mammalian liver has more kynureninase than kidney in which kynurenine transaminase is predominant although both enzymes are present in bacteria and moulds.
MATERIALS AND METHODS
We have examined 23 renal parenchymal tumours (Table I ) and 6 fragments of normal tissue from kidneys with a malignancy, since it was obviously impossible to have, as control, normal kidneys. Immediately after nephrectomy every organ was immersed in ice and divided into three portions, each of which was homogenized in a Waring Blendor for 2 minutes with 4 times its own weight of ice and phosphate buffer at a pH appropriate for each enzyme (see below). The homogenate was diluted to a 20 0 (w/v) concentration with 0*05 M buffer.
(1) Tryptophan pyrrolase was prepared and estimated according to Knox (1955) and to Knox and Auerbach (1955) and Marshall (1938) . The amounts of kynurenine were estimated at 10-20 minute intervals for approximately two hours and the results plotted against time and hence it was possible to calculate the micromoles of kynurenine accumulating per hour for each gram of supernatant protein.
(2) Kynureninase was prepared and measured according to a modification of Saran's method (1958) .
The frozen normal kidney and the neoplastic tissues were homogenized with cold 0-05 M phosphate buffer, pH 8, to prepare a 20 % mixture.
After freezing for a day at -20°C. it was thawed and centrifuged for 35 minutes at 9000 r.p.m. The assay mixture contained 1-0 ml. of supernatant fraction, 0-3 ml. of 0-00004 M pyridoxal-5-phosphate in 0-05 M phosphate buffer, pH 8, 1-6 ml. 0-05 M phosphate buffer, pH 8. After a 15 minute preincubation period at 370 C. 0-1 ml. of 0-01 M kynurenine in 0-05 M phosphate buffer, pH 8, was added.
From the incubation mixture were taken duplicate blanks of 1-2 ml. at zero time and text samples after 30 minute incubation.
The samples had 0-2 ml. of 15 % TCA added immediately to stop any enzyme reaction and were then centrifuged at 5000 r.p.m. for 10 minutes.
0.1 ml. supernatant was withdrawn and made to a final volume of 4 ml. with 0-1 M phosphate buffer, pH 8. The anthranilic acid formed was determined spectrofluorometrically with an Aminco-Bowman apparatus at 400 m,u (excitation 310 m,t) and derived from the standard curve obtained in the same experimental conditions.
Enzyme specific activity was expressed as flmoles of anthranilic acid formed per g. of protein per hour.
(3) Kynurenine transaminase was prepared and estimated by the method of Mason (1957) and was partially purified by means of ammonium sulphate fractionation.
All assays were performed in triplicate, with a 1-5 ml. mixture containing 1 ml. of enzyme solution, 0-15 ml. of 0-006 M a-ketoglutarate in 0-05 M phosphate buffer, pH 7-4 and 0-15 ml. of 0-0004 M pyridoxal-5-phosphate in the same buffer.
After a 15 minute preincubation period at 370 C. 0-2 ml. of 0-035 M L-kyniurenine in 0-05 M phosphate buffer, pH 7.4, was added. The reaction was stopped at zero time for blanks and after 30 minutes by means of 7-5 ml. of 95 % ethanol containing 1 % boric acid. Previous studies demonstrated a liiiear reaction rate during this time period.
After centrifuging at 9000 r.p.m. the formation of kynurenic acid was measured spectrophotometrically at 333 m,u against the blank containing the same components and deproteinizing agent added at zero time.
The amount of kynurenic acid formed was read from a calibration curve prepared under the same experimental conditions after adding known amounts of kynurenic acid.
Kynurenine transaminase activity was expressed as ,tmoles of kynurenic acid formed per g. protein per hour.
(4) The nitrogen content of enzyme solutions was determined by the microKjeldahl method.
(5) The 24 hours urines before nephrectomy were analysed for their content of tryptophan metabolites, by using the method of Benassi Veronese and Antoni (1963-64) . RESULTS Kynureninase values show large fluctuations both in normal and neoplastic kidney tissue. The activity does not significantly differ in normal and in oncogenic tissues. However, the activities are much lower than those obtained in this laboratory in analogous work on rat and guinea-pig kidney.
AND DISCUSSION
In the few cases in which it has been possible to isolate fragments of normal kidney, kynurenine transaminase results are slightly lower in the neoplastic portion than in the normal portion. However, the levels of this enzyme, somewhat higher than kynureninase, appear markedly reduced compared with that of other mammalian kidney when expressed as ,tmoles of product per g. protein per hour.
With an aim to relate the observed enzyme activities with the carcinogenic process the determination of main products of tryptophan degradation has been carried out in urine of the same patients 24 hours before nephrectomy and therefore just before the determination of kidney enzymic activities. The following abbreviations are used: K. kynurenine; 3 OHK, 3-hydroxykynurenine; 3 OHAA 3-hydroxyanthranilic acid; oAHA, o-aminohippuric acid; KA, kynurenic acid; XA, xanthurenic acid.
* Values refer to urine directly collected from kidney which was the site of the tumour. Underlined values refer to abnormally high excretion.
The data, reported in Table III , show that in some subjects the exeretory pattern of all metabolites is perfectly normal before surgical excision of tumour.
Several workers (Boyland and Williams, 1956; Price, 1958; Tompsett, 1959; Mainardi and Tenconi, 1964; Musajo and Benassi, 1964) agree that all humans fed a free diet excrete daily small amounts of tryptophan metabolites. According to a method recently set up in this laboratory (Benassi et al., 1963-64) Cases No. 6, No. 7, No. 14, No. 19 Case No. 15 shows exceptionally elev7ated levels of o-aminiohippuric and also of kivnureniic and xanithureniic acids.
In case No. 1 0 it was possible to examine urine passed per urethram and urine from the neoplastic kidney obtainied through ani ureteric catheter: both normal anid neoplastic kidneys excrete dailv the same quantities of metabolites and. except for 3-hydroxykynurenine and o-aminohipptiric acid, in an abnormal manner. This finding is better and confirmatory evidence of the previous results that no relationship exists between metabolite exeretion and kidney pathology and neither is there a relationship between the metabolites and the kidniey's own enzymes.
Upon tryptophan loading in a patient with a small hvpernephroma in the left kidney. Kerr et al. (1 l963) The data exclude a direct relationship betweeni the formation of urinary tryptophan metabolites and any particular enzvme activity of the tumour conlcerned in tryptophan degradation.
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